EUPRAXIA PHARMACEUTICALS INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 8.03 million shares as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-03-13
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 8.03M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 8.81M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 9.12M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2025-12-31 | 8.03M shares 40-F · filed 2026-03-13 |
| 2024-12-31 | 8.81M shares 40-F · filed 2025-03-20 |
| 2023-12-31 | 9.12M shares 40-F · filed 2024-04-01 |